Point72 (DIFC)’s Lunai Bioworks LNAI Stock Holding History

Point72 (DIFC)’s Portfolio LNAI Stock Details LNAI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-30	Closed	-$683	–	1758
2025 Q2	$683	Buy	+30	New	+$838	﹤0.01%	1449

Other funds holding LNAI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Point72 (DIFC)'s LNAI Position: Q3 2025 in Review

Point72 (DIFC) sold out of Lunai Bioworks (LNAI) in Q3 2025, closing a stake of 30 shares — an estimated $683 sold.

Point72 (DIFC) first reported a position in LNAI in Q2 2025 and held it in 1 quarter. The position peaked at $683 in Q2 2025. 20 funds tracked by Wall St. Rank hold LNAI as of Q3 2025.

Point72 (DIFC) reported no remaining Lunai Bioworks position as of Q3 2025 after selling out during the quarter.
Point72 (DIFC) sold 30 Lunai Bioworks shares in Q3 2025, an estimated $683.
Point72 (DIFC) first reported a position in Lunai Bioworks in Q2 2025 and held it in 1 quarter.
Point72 (DIFC)'s Lunai Bioworks position peaked at $683 in Q2 2025.
20 funds tracked by Wall St. Rank held Lunai Bioworks as of Q3 2025.

Based on Point72 (DIFC)'s 13F filing for Q3 2025, filed 14 Nov 2025.